Since previous researches confirmed enhanced activity of CYP24A1 in less differentiated colon cancer cells [14], [15], it would be expectable to find increased concentrations of 24,25(OH)2D3 in systemic circulation of CRC patients. This evidence concerns the gene CYP24A1 and colorectal carcinoma.